DBV Technologies (DBVT) Shares Outstanding (Diluted Average) (2021 - 2026)

DBV Technologies (DBVT) reported Shares Outstanding (Diluted Average) of $428.3 million for Q1 2026, up 317.38% year-over-year from $102.6 million in Q1 2025, and up 206.86% quarter-over-quarter from $139.6 million in Q4 2025.

DBV Technologies (DBVT) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $428.3 million in Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $428.3 million, up 317.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $428.3 million (up 317.38% YoY), and the FY2025 annual result was $139.6 million, up 43.9% from the prior year.
  • Shares Outstanding (Diluted Average) improved to $428.3 million in Q1 2026 per DBVT's latest filing, from $139.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $428.3 million in Q1 2026 and troughed at $54.9 million in Q1 2022.
  • A 5-year average of $115.2 million and a median of $96.2 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Diluted Average) increased 0.12% in 2024, then jumped 317.38% in 2026.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $77.4 million in 2022, then gained by 22.92% to $95.1 million in 2023, then increased by 1.97% to $97.0 million in 2024, then jumped by 43.9% to $139.6 million in 2025, then jumped by 206.86% to $428.3 million in 2026.
  • Business Quant data shows DBVT's Shares Outstanding (Diluted Average) at $428.3 million in Q1 2026, $139.6 million in Q4 2025, and $124.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 428.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 428.30 Mn
Dec 31, 2025 139.57 Mn
Sep 30, 2025 124.72 Mn
Jun 30, 2025 134.48 Mn
Mar 31, 2025 102.62 Mn
Dec 31, 2024 97.00 Mn
Sep 30, 2024 96.19 Mn
Jun 30, 2024 96.18 Mn
Mar 31, 2024 96.18 Mn
Dec 31, 2023 95.12 Mn
Sep 30, 2023 96.08 Mn
Jun 30, 2023 94.15 Mn
Mar 31, 2023 93.97 Mn
Dec 31, 2022 77.38 Mn
Sep 30, 2022 71.78 Mn
Jun 30, 2022 60.49 Mn
Mar 31, 2022 54.93 Mn
Dec 31, 2021 54.92 Mn
Sep 30, 2021 54.95 Mn
Jun 30, 2021 54.89 Mn